Renal tissue alterations were size-dependent with smaller ones induced more effects and related with time exposure of gold nanoparticles

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Abdelhalim, Mohamed Anwar K ^a   Jarrar, Bashir M ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b JOUF UNIVERSITY   (Saudi Arabia)

Author keywords

gold nanoparticles; histological alterations; hydropic degeneration; nanotoxicity; renal tissue

Indexed keywords

GOLD NANOPARTICLE; GOLD; METAL NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL DEGENERATION; CELL DESTRUCTION; CELL SWELLING; CELL VACUOLE; CONTROLLED STUDY; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; PARTICLE SIZE; RANDOMIZED CONTROLLED TRIAL; RAT; ANIMAL; CELL NUCLEUS; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; GLOMERULUS; INFUSION; KIDNEY; MATERIALS TESTING; PATHOLOGY; RANDOMIZATION; TIME; WISTAR KYOTO RAT;

ANIMALIA; RATTUS;

ANIMALS; CELL NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; GOLD; INFUSIONS, PARENTERAL; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TUBULES, PROXIMAL; MALE; MATERIALS TESTING; METAL NANOPARTICLES; PARTICLE SIZE; RANDOM ALLOCATION; RATS; RATS, INBRED WKY; TIME FACTORS;

EID: 80053172695     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-163     Document Type: Article

References (30)

1. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. Huang X, El-Sayed I, Qian W, El-Sayed M, J Am Chem Soc 2006 128 2115 20 10.1021/ja057254a 16464114 (Pubitemid 43277351)
2. Au nanoparticles target cancer. Jain P, El-Sayed I, El-Sayed M, Nanotoday 2007 2 18 29 (Pubitemid 46196541)
3. Therapeutic possibilitiesof plasmonically heated gold nanoparticles. Pissuwan D, Valenzuela S, M Cortie M, Trends in Biotechnol 2006 24 62 67 10.1016/j.tibtech.2005.12.004 (Pubitemid 43151977)
4. Nanotherapeutics for enhancing thermal therapy of cancer. Visaria R, Bischof J, Loren M, Williams B, Ebbini E, Paciotti G, R. Griffin R, Int J Hyperthermia 1007 23 6 501 511
5. Hyperthermic effects of gold nanorods on tumor cells. Huff T, Tong L, Zhao Y, Hansen M, Cheng JX, Wei A, Nanomed 2007 2 125 132, 10.2217/17435889.2.1. 125 (Pubitemid 46850567)
6. Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Chen J, Wang D, Xi J, Au L, A. Siekkinen A, Warsen A, Li Y, Zhang H, Xia Y, Li X, Nano Lett 2007 7 1318 1322 10.1021/nl070345g 17430005 (Pubitemid 46834416)
7. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Lanone S, Boczkowski J, Curr Mol Med 2006 6 651 63 10.2174/156652406778195026 17022735 (Pubitemid 44377764)
8. Translocation and effects of gold nanoparticles after inhalation exposure in rats. Yu LE, Yung L-YL, Balasubramaniam KS, Hartono D, Nanotoxicology 2007 1 3 235 42 10.1080/17435390701763108 (Pubitemid 350179071)
9. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD, Small 2005 1 3 325 327 10.1002/smll.200400093 17193451 (Pubitemid 43951781)
10. Modification of gold nanorods using phosphatidylcholineto reduce cytotoxicity. Takahashi H, Niidome Y, Niidome T, Kaneko K, Kawasaki H, Yamada S, Langmuir 2006 22 1 2 5 10.1021/la0520029 16378388 (Pubitemid 43063513)
11. Size-dependent cytotoxicity of gold nanoparticles. Neuss S, Leifert A, Fischler M, Wen F, Simon U, et al. Small 2007 3 11 1941 1949 10.1002/smll.200700378 17963284 (Pubitemid 350099867)
12. Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD. MacNee W, Donaldson K, Eur Respir 2003 21 40 47S 51S 10.1183/09031936.03.00403203 (Pubitemid 36565582)
13. Potential oxidative stress of gold Nanoparticles by induced-NO releasing in serum. Jia HY, Liu Y, Zhang XJ, Han L, Du LB, Tian Q, J am Chem Soc 2009 131 1 40 1 10.1021/ja808033w 19072650
14. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Chithrani BD, Chan WC, Nano Lett 2007 7 1542 1550 10.1021/nl070363y 17465586 (Pubitemid 47140422)
15. Size-dependent cytotoxicity of gold nanoparticles. Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W, Small 2007 3 1941 1949 10.1002/smll.200700378 17963284 (Pubitemid 350099867)
16. Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. BarathManiKanth S, Kalishwaralal K, Sriram M, Pandian SRK, Youn H, Eom S, Gurunathan S, Journal of Nanobiotechnology 2010 8 16 10.1186/1477-3155-8-16 20630072
17. In vitro toxicity of nanoparticles in BRL- 3A rat liver cells. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ, Toxicol in Vitro 2005 19 975 983 10.1016/j.tiv.2005.06.034 16125895 (Pubitemid 41563236)
18. Can silver nanoparticles be useful as potential biological labels? Schrand AM, Bradich-Stolle LK, Schlager JJ, Dai L, Hussain SM, Nanotechnology 2008 9 1 13
19. Perturbational profiling of nanomaterial biologic activity. Shaw SY, Westly EC, Pittet MJ, Subramanian A, Schreiber SL, Weissleder R, Proc Natl Acad Sci USA 2008 105 7387 7392 10.1073/pnas.0802878105 18492802 (Pubitemid 351830027)
20. Paclitaxel-functionalized gold nanoparticles. Gibson JD, Khanal BP, Zubarev ER, J Am Chem Soc 129 2007 11653 11661 (Pubitemid 47555582)
21. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. De Jong W, Hagens W, Krystek P, Burger M, Sips A, Geertsma R, Biomater 2008 29 12 1912 1919 10.1016/j.biomaterials.2007.12.037
22. Gum rabic as a phytochemical construct for the stabilization of gold nanoparticles: In vivo pharmacokinetics and x-ray-contrast-imaging studies. Kattumuri V, Katti K, Bhaskaran S, Boote E, Casteel S, Fent G, Robertson D, Chandrasekhar M, Kannan R, Katti K, Small 2007 3 333 341 10.1002/smll.200600427 17262759
23. Histochemistry. Theoritical and applied. Pearse AE, Analytical technology Churchill-Livingstone, Edinburgh 4 1985 2
24. Tracking gold nanoparticles in the body. Terentyuk G, Maslyyakova G, Suleymanova L, Kogan B, Khlebtsov B, Akchurin G, Makisimova I, Shantrokha A, Tuchin V, J Biomedical Optics 2009 14 19 16
25. Swelling of hepatocytes injured by oxidative stress suggests pathological changes related to macromolecular crowding. Del Monte U, Medical Hypotheses 2005 64 4 818 825 10.1016/j.mehy.2004.08.028 15694703 (Pubitemid 40203072)
26. Metal-based nanoparticles and their toxicity assessment. Schrand AM, Rahman MF, Hussain SM, Schlager JJ, David A, Smith DA, Syed AF, Nanomed Nanobiotechnol 2010 2 544 568 10.1002/wnan.103
27. Nuclear polymorphism and nuclear size in precarcinomatous and carcinomatous lesions in rat colon and liver. Zusman I, Kozlenko M, Zimber A, Cytometry 1991 12 4 302 7 10.1002/cyto.990120403 2065554
28. Robbins Basic Pathology. Kumar V, Abbas A, Nelson F, Mitchell R, Robbins Basic Pathology 2007 6 9 10
29. Apoptosis: Condensed matter in cell death. Zamzami N, Kroemer G, Nature 1999 401 127 127 8 10490018 (Pubitemid 29436304)
30. Robbins Pathologic Basis of Disease. Cotran, Kumar, Collins, Philadelphia: W.B Saunders Company 1998